Products incorporating Skyepharma's technologies

Skyepharma’s proprietary drug delivery technologies have been incorporated into many approved products that are sold by pharmaceutical companies in over 80 countries, where they provide important clinical benefits for patients and offer additional proprietary protection.

We have partnered with a wide range of companies, from big pharma such as GlaxoSmithKline, Novartis, Sanofi, Janssen and Roche, to medium-sized companies like Mundipharma and Kyorin, and smaller specialty pharmaceutical companies. We use our know-how and capabilities, and where appropriate apply Our proprietary drug delivery technologies and expertise to the development of pharmaceutical products in order to improve patient outcomes and provide additional proprietary protection for our partners.

Find out more about inhalation and oral products that incorporate our drug delivery technologies and that we have helped to develop. We are also developing some novel products of our own.

Contact us if you would like to discuss potential collaboration with Skyepharma.

Range of oral modified release and inhalation pharmaceutical products, developed by Skyepharma

Copyright 2014, Skyepharma. All Rights Reserved. Skyepharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 46-48 Grosvenor Gardens, London SW1W 0EB, United Kingdom

Contact addresses

Skyepharma PLC
46-48 Grosvenor Gardens
London
SW1W 0EB
UK

Tel: +44 207 881 0524

Fax: +44 207 881 1199

E-mail us

Skyepharma AG
Eptingerstrasse 61
4132 Muttenz
Switzerland

Tel: +41 61 467 5555

Fax: +41 61 467 5500

E-mail us

This website works best using cookies.